mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.7 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |